Clinical Trials Browser

Phase 3 × Osteosarcoma × 30 days × Clear all

NCT06935409 2026-04-09

Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure

Phase 3 Active not recruiting

Osteosarcoma